Audio By Carbonatix
Uganda will begin human trials of a Covid-19 vaccine in November, the Daily Monitor newspaper reports quoting ministry of health officials.
The vaccine, called Self Replicating RNA, has been developed through a partnership between Uganda Virus Research Institute (UVRI) and Imperial College in the UK.
The head of a presidential taskforce on epidemics, Monica Musenero, is quoted as saying the first trial will be conducted on 10 Ugandans.
If successful, a second trial will involve about 100 to 200 people followed by a final trial of between 1,000 and 3,000 people, she said.
The bulk of the project is being financed by the UK university.
The East Africa country has to date confirmed more than 7,000 coronavirus cases and 75 deaths.
Latest Stories
-
Mercy Johnson faces backlash over $18.24 menstrual kit
45 minutes -
EU plans to fine Google high triple-digit million euro sum, Handelsblatt reports
54 minutes -
Senegal’s Faye names economist Lo as new prime minister
1 hour -
Landslide at Angola illegal gold mine kills 28
1 hour -
The Draft NITA Bill should be shredded
1 hour -
Eni and partners approve new development phase for Ivory Coast project
1 hour -
Govt signals tougher scrutiny before renewing Gold Fields’ Tarkwa lease, Reuters report
2 hours -
Africa must build strong systems to achieve sporting success — Herbert Mensah
2 hours -
Gunmen abduct 25 people in twin attacks in Nigeria’s Kwara state, police say
2 hours -
Ebola patients flee in attacks on Congo health facilities, hobbling response
2 hours -
What Is Wrong with Us: Why we keep uprooting young trees because they have not yet become forests
2 hours -
Senegal’s parliament speaker quits two days after prime minister sacked
2 hours -
WHO chief says fast-moving Ebola epidemic is outpacing response efforts
2 hours -
Rubio says Strait of Hormuz has to be open ‘one way or the other’Â
2 hours -
Cocoa farmers, patients and consumers paying price for governance failures – CDM
3 hours